BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8960305)

  • 1. Simultaneous expression of the ras p21 and p53 proteins in human endometrial carcinomas.
    Miturski R; Semczuk A; Jakowicki J
    Acta Histochem; 1996 Nov; 98(4):411-8. PubMed ID: 8960305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ras p21 in the stromal cells of human neoplastic endometrium.
    Miturski R; Semczuk A; Jakowicki JA
    Eur J Gynaecol Oncol; 1998; 19(3):308-11. PubMed ID: 9641239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53 and ras p21 protein expression in surgically treated non-small cell lung carcinoma.
    Cohen R; Guber A; Koren R; Marom Z; Siegal A
    Rom J Morphol Embryol; 1998; 44(1-4):117-23. PubMed ID: 15678852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras p21 immunohistochemical detection in human endometrial carcinomas.
    Semczuk A; Miturski R; Baranowski W; Jakowicki JA
    Gynecol Obstet Invest; 1997; 44(2):132-5. PubMed ID: 9286729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-2 and P53 expression in endometrial carcinoma.
    Erkanli S; Eren F; Pekin S; Bagis T
    J Exp Clin Cancer Res; 2004 Mar; 23(1):97-103. PubMed ID: 15149157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus.
    Jiko K; Sasano H; Ito K; Ozawa N; Sato S; Yajima A
    Anticancer Res; 1993; 13(2):305-10. PubMed ID: 8517643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB protein expression in human endometrial carcinomas--an immunohistochemical study.
    Semczuk A; Schneider-Stock R; Miturski R; Skomra D; Tomaszewski J; Roessner A; Jakowicki JA
    Pathol Res Pract; 2000; 196(1):41-6. PubMed ID: 10674271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between p53 expression, stage and histological features in endometrial cancer.
    Ragni N; Ferrero S; Prefumo F; Muschiato B; Gorlero F; Gualco M; Fulcheri E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):111-6. PubMed ID: 15894417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
    Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
    Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 and p21 Ki-ras proteins in rat thyroid gland tumors induced by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
    Hakulinen P; Kosma VM; Komulainen H
    Anticancer Res; 2002; 22(2A):703-6. PubMed ID: 12014640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
    Wang J; Dong F; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the c-H-ras1 gene by the P53 protein is implicated in the development of human endometrial and ovarian tumours.
    Zachos G; Spandidos DA
    Oncogene; 1998 Jun; 16(23):3013-7. PubMed ID: 9662334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
    Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
    Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma.
    Hamada M; Naomoto Y; Shirakawa Y; Yamatsuji T; Noma K; Motoki T; Nobuhisa T; Okawa T; Haisa M; Gunduz M; Matsuoka J; Tanaka N
    Oncol Rep; 2004 Jan; 11(1):57-63. PubMed ID: 14654903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
    Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.